Learn what a TRT assessment involves, how suitability is decided and what ongoing clinical review may include.
Takes about 5 minutes. Includes an eligibility review. Any pathology your practitioner requires is privately billed by a third party and is not part of your consultation fee.
Register your interest and Regeniq will let you know when the TRT assessment pathway opens.
When invited, complete the dedicated TRT questionnaire so the practitioner has the information needed for an initial review.
An Australian practitioner reviews your information and decides what assessment steps are appropriate. Joining the waitlist does not guarantee eligibility or treatment.
Possible symptoms can include lower energy, reduced libido, changes in mood, difficulty concentrating, reduced strength or slower recovery.
These symptoms are not specific to low testosterone and do not confirm a diagnosis. Sleep, stress, medicines and other health conditions can produce similar changes, so assessment matters.
Your practitioner reviews your symptoms, health history, current medicines, fertility plans and other factors that may affect suitability.
If your practitioner decides pathology is needed, they request a morning blood test; it is performed and privately billed by a third-party provider. A result is considered alongside the broader clinical picture rather than on its own.
TRT is not suitable for everyone. It may not be appropriate where a practitioner identifies a contraindication, an unresolved health risk or a need for specialist assessment.
Fertility plans, existing conditions, current medicines and previous results can all affect the decision. Your practitioner will explain any concerns and discuss appropriate next steps.
If TRT is prescribed, ongoing care may include review of symptoms, treatment response, side effects and relevant clinical markers. Your practitioner sets the timing and decides whether treatment should continue or change.
If your practitioner decides further pathology is needed, they request it; it is performed and privately billed by a third-party provider.
Join the waitlist to hear when Regeniq opens its TRT assessment pathway. Joining does not confirm eligibility or access to treatment.
Treatment plans are personalised and prescribed only after medical consultation. Not all patients are suitable candidates. Risks and benefits will be discussed during your consultation. Medicare and private health insurance do not cover these services.
